The University of Chicago Header Logo

Connection

Pablo Sanchez to Lung

This is a "connection" page, showing publications Pablo Sanchez has written about Lung.
Connection Strength

5.731
  1. Heparanase-induced endothelial glycocalyx degradation exacerbates lung ischemia/reperfusion injury in male mice. Physiol Rep. 2024 Oct; 12(20):e70113.
    View in: PubMed
    Score: 0.607
  2. Performance status at the time of lung retransplant predicts long-term function. Clin Transplant. 2024 04; 38(4):e15310.
    View in: PubMed
    Score: 0.586
  3. Human Lung-Resident Macrophages Colocalize with and Provide Costimulation to PD1hi Tissue-Resident Memory T Cells. Am J Respir Crit Care Med. 2021 05 15; 203(10):1230-1244.
    View in: PubMed
    Score: 0.480
  4. Extracorporeal Membrane Oxygenation to Overcome Graft-Cavity Disparity of Lung Transplantation. Ann Thorac Surg. 2020 04; 109(4):e275-e277.
    View in: PubMed
    Score: 0.426
  5. Defining quality during ex vivo lung perfusion: The University of Maryland experience. J Thorac Cardiovasc Surg. 2015 Nov; 150(5):1376-7.
    View in: PubMed
    Score: 0.319
  6. Ex vivo lung evaluation of prearrest heparinization in donation after cardiac death. Ann Surg. 2013 Mar; 257(3):534-41.
    View in: PubMed
    Score: 0.272
  7. Ex-vivo lung perfusion. Curr Opin Organ Transplant. 2012 Oct; 17(5):490-5.
    View in: PubMed
    Score: 0.264
  8. National Emphysema Treatment Trial redux: accentuating the positive. J Thorac Cardiovasc Surg. 2010 Sep; 140(3):564-72.
    View in: PubMed
    Score: 0.229
  9. Lung transplantation in primary pulmonary arterial hypertension and pulmonary venous hypertension. Clin Transplant. 2024 01; 38(1):e15158.
    View in: PubMed
    Score: 0.142
  10. Expanding Donor Options for Lung Transplant: Extended Criteria, Donation After Circulatory Death, ABO Incompatibility, and Evolution of Ex Vivo Lung Perfusion. Transplantation. 2023 07 01; 107(7):1440-1451.
    View in: PubMed
    Score: 0.139
  11. Intraoperative Red Blood Cell Transfusion and Primary Graft Dysfunction After Lung Transplantation. Transplantation. 2023 07 01; 107(7):1573-1579.
    View in: PubMed
    Score: 0.137
  12. Endothelial protection in lung grafts through heparanase inhibition during ex vivo lung perfusion in rats. J Heart Lung Transplant. 2023 06; 42(6):697-706.
    View in: PubMed
    Score: 0.136
  13. Single-center experience of ex vivo lung perfusion and subsequent lung transplantation. Clin Transplant. 2023 02; 37(2):e14901.
    View in: PubMed
    Score: 0.135
  14. Lung transplantation from donation after circulatory death, evolution, and current status in the United States. Clin Transplant. 2023 03; 37(3):e14884.
    View in: PubMed
    Score: 0.134
  15. Outcomes following lung re-transplantation in patients with cystic fibrosis. J Cyst Fibros. 2022 05; 21(3):482-488.
    View in: PubMed
    Score: 0.125
  16. Rapid postmortem ventilation improves donor lung viability by extending the tolerable warm ischemic time after cardiac death in mice. Am J Physiol Lung Cell Mol Physiol. 2021 10 01; 321(4):L653-L662.
    View in: PubMed
    Score: 0.122
  17. Heparanase inhibition preserves the endothelial glycocalyx in lung grafts and improves lung preservation and transplant outcomes. Sci Rep. 2021 06 10; 11(1):12265.
    View in: PubMed
    Score: 0.121
  18. Month-long Respiratory Support by a Wearable Pumping Artificial Lung in an Ovine Model. Transplantation. 2021 05 01; 105(5):999-1007.
    View in: PubMed
    Score: 0.120
  19. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction. J Heart Lung Transplant. 2020 12; 39(12):1417-1425.
    View in: PubMed
    Score: 0.115
  20. Cyclosporin A Administration During Ex Vivo Lung Perfusion Preserves Lung Grafts in Rat Transplant Model. Transplantation. 2020 09; 104(9):e252-e259.
    View in: PubMed
    Score: 0.114
  21. Ex Vivo Lung Perfusion: A Review of Research and Clinical Practices. Semin Cardiothorac Vasc Anesth. 2020 Mar; 24(1):34-44.
    View in: PubMed
    Score: 0.110
  22. Sending our lungs to rehab: The future of ex vivo lung perfusion? J Thorac Cardiovasc Surg. 2018 08; 156(2):908-909.
    View in: PubMed
    Score: 0.097
  23. A Novel Large Animal Model of Acute Respiratory Distress Syndrome Induced by Mitochondrial Products. Ann Surg. 2017 12; 266(6):1091-1096.
    View in: PubMed
    Score: 0.095
  24. Current state of ex-vivo lung perfusion. Curr Opin Organ Transplant. 2016 06; 21(3):258-66.
    View in: PubMed
    Score: 0.085
  25. Predictive equations for lung volumes from computed tomography for size matching in pulmonary transplantation. J Thorac Cardiovasc Surg. 2016 Apr; 151(4):1163-9.e1.
    View in: PubMed
    Score: 0.082
  26. State of art: clinical ex vivo lung perfusion: rationale, current status, and future directions. J Heart Lung Transplant. 2012 Apr; 31(4):339-48.
    View in: PubMed
    Score: 0.064
  27. Thirty-day in-vivo performance of a wearable artificial pump-lung for ambulatory respiratory support. Ann Thorac Surg. 2012 Jan; 93(1):274-81.
    View in: PubMed
    Score: 0.062
  28. Ex vivo lung perfusion in donation after circulatory death: A post hoc analysis of the Normothermic Ex Vivo Lung Perfusion as an Assessment of Extended/Marginal Donors Lungs trial. J Thorac Cardiovasc Surg. 2024 Sep; 168(3):724-734.e7.
    View in: PubMed
    Score: 0.037
  29. Chronic lung allograft dysfunction is associated with an increased number of non-HLA antibodies. J Heart Lung Transplant. 2024 Apr; 43(4):663-672.
    View in: PubMed
    Score: 0.036
  30. Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications. Am J Transplant. 2023 10; 23(10):1590-1602.
    View in: PubMed
    Score: 0.035
  31. Newly synthesized glycoprotein profiling to identify molecular signatures of warm ischemic injury in donor lungs. Am J Physiol Lung Cell Mol Physiol. 2023 07 01; 325(1):L30-L44.
    View in: PubMed
    Score: 0.034
  32. Remote ex vivo lung perfusion at a centralized evaluation facility. J Heart Lung Transplant. 2022 12; 41(12):1700-1711.
    View in: PubMed
    Score: 0.033
  33. Cross-Regulation of F-Box Protein FBXL2 with T-bet and TNF-a during Acute and Chronic Lung Allograft Rejection. J Immunol. 2022 11 01; 209(9):1788-1795.
    View in: PubMed
    Score: 0.033
  34. Shock lung is not "wet" but characterized as necroptotic inflammation in a mouse model of hypotension. J Thorac Cardiovasc Surg. 2023 02; 165(2):e40-e53.
    View in: PubMed
    Score: 0.032
  35. Rate of recipient-derived alveolar macrophage development and major histocompatibility complex cross-decoration after lung transplantation in humans. Am J Transplant. 2022 02; 22(2):574-587.
    View in: PubMed
    Score: 0.031
  36. Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients. Clin Infect Dis. 2021 08 02; 73(3):416-426.
    View in: PubMed
    Score: 0.030
  37. Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction. Am J Transplant. 2021 06; 21(6):2145-2160.
    View in: PubMed
    Score: 0.029
  38. Strategic application of modular risk components to safely increase lung transplantation volume. J Card Surg. 2020 Sep; 35(9):2177-2184.
    View in: PubMed
    Score: 0.028
  39. Anesthetic management of lung transplantation: Results from a multicenter, cross-sectional survey by the society for advancement of transplant anesthesia. Clin Transplant. 2020 08; 34(8):e13996.
    View in: PubMed
    Score: 0.028
  40. Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival. Am J Transplant. 2020 05; 20(5):1439-1446.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.